CDC Logo Skip Top Nav
 CDC Home PageSearch the CDCHealth Topics A though Z
Skip
Division of Tuberculosis Elimination
About DTBE Upcoming Events Site Map CDC en Espanol Contact Us
 

2001 Surveillance Slides

This is an archived document. The links and content are no longer being updated.

Return to 2001 Surveillance Slides Main Menu

Primary Isoniazid Resistance in U.S.-born vs. Foreign-born Persons

United States, 1993-2001


Tuberculosis in the United States
Slide 20: Primary Isoniazid Resistance in U.S.-born vs. Foreign-born Persons, United States, 1993-2001. This graph shows primary isoniazid resistance in U.S.-born vs. foreign-born persons. Among foreign-born persons, the percentage of isoniazid resistance (based on initial isolates from persons with no prior history of TB) was approximately two times higher than among U.S.-born persons. The percentage declined from 12.4 in 1993 to 9.6 in 2001 among foreign-born persons, while it decreased from 6.8 in 1993 to 4.5 in 2001 among U.S.-born persons.
Surveillance Slides Previous Slide Next Slide Last Slide
Back to 2001 Surveillance Slides Main Page

Last Reviewed: 05/18/2008
Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Back to Top of Page


You will need Adobe Acrobat™ Reader v5.0 or higher to read pages that are in PDF format.  Download the Adobe Acrobat™ Reader.

If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available.

Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348
E-mail: tbinfo@cdc.gov


Skip Bottom Nav Home | Site Map | Contact Us
Accessibility | Privacy Policy Notice | FOIA | USA.gov
CDC Home | Search | Health Topics A-Z

Centers for Disease Control & Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Please send comments/suggestions/requests to: CDCINFO@cdc.gov